MODELING OF THE RESEARCH AND DEVELOPMENT PROCESS FOR A NEW DRUG TO ASSESS THE COSTS AND LIKELIHOOD OF SUCCESS AT EACH STAGE

D. V. Shuvalova () and N. S. Rostovsky ()

Russian Journal of Industrial Economics, 2015, issue 1

Abstract: The structure and functioning of clusters in the pharmaceutical industry were investigated here as the most effective structure to ensure superiority over the competition, innovation, education, the relationship between enterprises. The model of estimating the probability of successful development of new drugs and the cost of innovations for a Big-Pharma company is presented in this article, taking into account the interaction between pharmaceutical companies, costing each of the stages of R&D process, as well as the probability of passing each stage of development.

Date: 2015
References: Add references at CitEc
Citations:

Downloads: (external link)
https://ecoprom.misis.ru/jour/article/viewFile/104/96 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ach:journl:y:2015:id:104

DOI: 10.17073/2072-1633-2012-1-122-128

Access Statistics for this article

More articles in Russian Journal of Industrial Economics from MISIS
Bibliographic data for series maintained by Главный контакт редакции ().